What a $100 Investment in FactSet Would Mean Today
The Growth of FactSet Research Systems Stock
Investing can be a transformative experience, and the journey of FactSet Research Systems illustrates this perfectly. Over the past two decades, FactSet (FDS) has shown remarkable resilience and potential, managing to outperform the market consistently. An investment of just $100 made 20 years ago in FDS stock has blossomed spectacularly, highlighting the importance of long-term investment strategies.
An Overview of FactSet's Financial Success
FactSet Research Systems, recognized by its stock ticker FDS, has delivered astonishing annualized returns of 14.36%. This figure surpasses the general market average by 5.66%, showcasing the company’s strong financial health. As of now, FactSet boasts a market capitalization of approximately $17.90 billion, indicating a robust presence in the financial services sector.
Investment Growth Explained
If you had invested $100 in FactSet twenty years ago, that investment would have grown to about $1,464.09 based on a share price of $470.46 at the current time. Such impressive growth rates illustrate how compounded annual returns work to multiply your initial investment significantly over the long term.
The Impact of Compounded Returns
Compounding is often called the eighth wonder of the world in finance, and FactSet's stock performance is a prime example of this concept. The longer you hold onto an investment, the more you benefit from the compounding effect, where not just your original investment but also the gains earned on that investment start generating returns.
This phenomenon is crucial for investors to understand, as it emphasizes the benefits of patience and long-term commitment in investing. FactSet’s track record demonstrates very clearly that investments can yield substantial returns when allowed to thrive over time, encouraging a buy-and-hold strategy.
Why FactSet is a Standout Investment
Companies like FactSet demonstrate resilience and the ability to adapt in a changing economic landscape. Investors have witnessed continued strength and growth even during market fluctuations. With a robust business model and consistent revenue growth, FDS remains an attractive option for both new and seasoned investors.
Future Outlook for FactSet
The future looks bright for FactSet Research Systems as it continues to innovate and expand its services in the financial technology space. With increasing reliance on data and analytics in investment decision-making, FactSet is well-positioned to capture a larger share of the market moving forward.
Frequently Asked Questions
How much would a $100 investment in FactSet be worth today?
A $100 investment in FactSet made 20 years ago would be worth approximately $1,464.09 today.
What is the annualized return of FactSet over the past 20 years?
FactSet has achieved an average annualized return of 14.36% over the past two decades, outperforming the market by 5.66%.
Why is compounding important in investing?
Compounding allows your investment to grow exponentially as you earn returns on both your initial investment and the gains accumulated over time.
What defines FactSet’s market position?
FactSet holds a strong market position with a market capitalization of around $17.90 billion, marking its influence in the financial services industry.
Can FactSet continue to grow in the future?
Yes, with its commitment to innovation and the increasing importance of data in financial decision-making, FactSet is poised for continued growth.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- ARK Invest Shifts Focus: Moderna Sold, Intellia and Tempus Gained
- Japan Experiences First Drop in Exports in Ten Months
- Market Signals Shift: Insights on Investor Behavior Today
- FTI Consulting Welcomes Sunny Yi as New Transformation Leader
- Innovent Biologics Achieves Major Breakthrough in Ulcerative Colitis Treatment
- CNOOC Limited Expands Exploration with New Concession Contracts
- Market Trends: Wall Street Anticipates TSMC Earnings Insights
- Mercer International Inc. Reports Solid Q3 Financial Outcomes
- Enovix Set to Present Q3 2024 Results and Future Plans
- Kamala Harris' Plan for Cannabis: Empowering Black Communities
Recent Articles
- Senseonics Unveils New Era for Diabetes Care with Eversense 365
- Global Technology Acquisition Corp. I Initiates Liquidation Process
- Unicycive Therapeutics CEO to Speak at Maxim Healthcare Summit
- Tevogen Bio Celebrates Community Recognition and Innovations
- Anil Kapur Joins Nurix Therapeutics Board of Directors
- Collaborative Innovations: Israel Acquisitions Teams with Gadfin
- Lithium Argentina Reports Third Quarter 2024 Financials Soon
- Home Federal Bancorp Increases Shareholder Value with Dividend
- Market Analysis: Record Highs Despite Volatile Earnings Reports
- Significant Changes in Cannabis Stock Market Performance
- Shivoo Studios Launches 'Skooly Toonz' Featuring 3D Animation
- Farmers & Merchants Bancorp Delivers Stellar Q3 2024 Performance
- Q2 Holdings, Inc. Set to Share Third Quarter Financial Insights
- Understanding Domino's Pizza Stock: A Deep Dive Into P/E Ratio
- Kopin Corp Faces Nasdaq Challenges Amid Technological Advances
- First Industrial Realty Trust Signals Growth with Q3 2024 Success
- Regions Financial Corporation Announces Latest Dividend Payments
- Lithium Argentina's Next Earnings Reveal Promising Insights
- Florida Sheriff Advocates for Cannabis Legalization with Values
- Leadership Transition at West Coast Community Bancorp Unveiled
- Cemtrex Implements Reverse Stock Split to Restructure Warrant Prices
- Agilent Technologies Sets Date for Fiscal Q4 2024 Results
- Royalty Pharma Set to Reveal Q3 2024 Results Next Month
- Community Financial System: Strengthening Returns through Dividends
- Brinker International to Announce Q1 Fiscal 2025 Results Soon
- Inno Holdings Navigates Nasdaq Challenges Amid Stock Split Moves
- First Industrial Realty Trust's Impressive Q3 Performance Unveiled
- MarketAxess Sets Conference Call for Q3 2024 Financial Insights
- Prosperity Bancshares Announces Increased Dividend for Shareholders
- Ceribell, Inc. Advances Patient Care with Groundbreaking Technology
- Insights into American Lithium's Q2 Performance and Future Prospects
- Vision RNG Receives $207 Million to Boost RNG Projects in Ohio
- Community Healthcare Trust Secures $400 Million Credit Facility Update
- Teladoc Health's Upcoming Financial Breakdown for Q3 2024
- Penske Automotive's Dividend Hike and Strategic Growth Initiatives
- Farmers & Merchants Bancorp Achieves Record Earnings Growth
- Columbus McKinnon Announces Second Quarter Earnings Call Plans
- Nevro Corp. Grants New Employee Inducement Awards for Growth
- Union Bankshares' Q3 Earnings Decline Amid Stable Growth
- Kinder Morgan Reports Q3 Results and Lowers Full-Year Guidance
- Senseonics Announces Innovative CGM System Virtual Event
- DuPont Declares Quarterly Dividend to Shareholders Impacting 2024
- Lexicon Partners with Viatris for Global Sotagliflozin Sales
- NeuroPace Strengthens Leadership with New HR Vice President
- Steel Dynamics Delivers Strong Q3 2024 Performance Metrics
- Capricor Therapeutics Announces Strategic Public Offering Plans
- Unicycive Therapeutics Engages in Discussion at Healthcare Summit
- Coherent Corp. Announces Inducement Grants for New CFO
- Signing Day Sports Announces Warrant Price Reduction Strategy
- Viatris Strengthens Portfolio with Lexicon Licensing Deal